Tags

Type your tag names separated by a space and hit enter

Long-term results of maintenance of lacrimal silicone stent in patients with functional epiphora after external dacryocystorhinostomy.
Eye (Lond). 2020 Apr; 34(4):669-674.E

Abstract

PURPOSE

To evaluate long-term outcomes of maintenance of lacrimal silicone stent for the management of functional epiphora after anatomically patent external dacryocystorhinostomy (DCR).

METHODS

We retrospectively reviewed the medical records of 101 eyes of 75 patients who were diagnosed to have functional epiphora after external DCR from 2005 to 2014. Functional epiphora was defined as epiphora that persisted or recurred even after patent DCR confirmed by a lacrimal irrigation test. Secondary silicone intubation was indicated when the patients wanted a further intervention. The stent was intended to be kept in situ unless there was a stent-related complication or the patient wanted removal.

RESULTS

In total, 34 of 75 patients (45.3%, 52 eyes) who agreed to the intervention underwent secondary silicone intubation. The success rates at 1, 3, and 5 years after surgery were 96.2%, 75.5%, and 70.2%, respectively. At the final follow-up (mean 72.7 ± 26.4 months), 32 (61.5%) eyes chose to retain the silicone tube: silicone stent was well maintained without epiphora and complications once inserted in 18 eyes (34.6%), whereas tube replacement was needed in 14 eyes (26.9%) because of nasal crust or whitish plaque formation on the tube surface. In 13 cases (25.0%), silicone stent was removed because of tube-related complications, and the most common complication was canaliculitis (n = 8, 15.4%).

CONCLUSIONS

Secondary intubation and maintenance of the stent is an effective and simple procedure for functional epiphora. The main obstacle to long-term maintenance is tube-associated canaliculitis.

Authors+Show Affiliations

Department of Ophthalmology, Hallym University Sacred Heart Hospital, Anyang, Korea.Barun Seoul Eye Clinic, Seongnam, Korea.Department of Ophthalmology Seoul National University Hospital, Seoul, Korea.Department of Ophthalmology, Kangdong Sacred Heart Hospital, Hallym University Medical Center, Seoul, Korea.Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Korea.Department of Ophthalmology, Boramae Medical Center, Seoul, Korea. Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea.Department of Ophthalmology Seoul National University Hospital, Seoul, Korea. khwarg@snu.ac.kr. Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea. khwarg@snu.ac.kr.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31527764

Citation

Lee, Min Joung, et al. "Long-term Results of Maintenance of Lacrimal Silicone Stent in Patients With Functional Epiphora After External Dacryocystorhinostomy." Eye (London, England), vol. 34, no. 4, 2020, pp. 669-674.
Lee MJ, Park J, Yang MK, et al. Long-term results of maintenance of lacrimal silicone stent in patients with functional epiphora after external dacryocystorhinostomy. Eye (Lond). 2020;34(4):669-674.
Lee, M. J., Park, J., Yang, M. K., Choi, Y. J., Kim, N., Choung, H. K., & Khwarg, S. I. (2020). Long-term results of maintenance of lacrimal silicone stent in patients with functional epiphora after external dacryocystorhinostomy. Eye (London, England), 34(4), 669-674. https://doi.org/10.1038/s41433-019-0572-2
Lee MJ, et al. Long-term Results of Maintenance of Lacrimal Silicone Stent in Patients With Functional Epiphora After External Dacryocystorhinostomy. Eye (Lond). 2020;34(4):669-674. PubMed PMID: 31527764.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term results of maintenance of lacrimal silicone stent in patients with functional epiphora after external dacryocystorhinostomy. AU - Lee,Min Joung, AU - Park,Jinku, AU - Yang,Min Kyu, AU - Choi,Youn Joo, AU - Kim,Namju, AU - Choung,Ho-Kyung, AU - Khwarg,Sang In, Y1 - 2019/09/16/ PY - 2019/03/15/received PY - 2019/08/13/accepted PY - 2019/07/25/revised PY - 2021/04/01/pmc-release PY - 2019/9/19/pubmed PY - 2019/9/19/medline PY - 2019/9/19/entrez SP - 669 EP - 674 JF - Eye (London, England) JO - Eye (Lond) VL - 34 IS - 4 N2 - PURPOSE: To evaluate long-term outcomes of maintenance of lacrimal silicone stent for the management of functional epiphora after anatomically patent external dacryocystorhinostomy (DCR). METHODS: We retrospectively reviewed the medical records of 101 eyes of 75 patients who were diagnosed to have functional epiphora after external DCR from 2005 to 2014. Functional epiphora was defined as epiphora that persisted or recurred even after patent DCR confirmed by a lacrimal irrigation test. Secondary silicone intubation was indicated when the patients wanted a further intervention. The stent was intended to be kept in situ unless there was a stent-related complication or the patient wanted removal. RESULTS: In total, 34 of 75 patients (45.3%, 52 eyes) who agreed to the intervention underwent secondary silicone intubation. The success rates at 1, 3, and 5 years after surgery were 96.2%, 75.5%, and 70.2%, respectively. At the final follow-up (mean 72.7 ± 26.4 months), 32 (61.5%) eyes chose to retain the silicone tube: silicone stent was well maintained without epiphora and complications once inserted in 18 eyes (34.6%), whereas tube replacement was needed in 14 eyes (26.9%) because of nasal crust or whitish plaque formation on the tube surface. In 13 cases (25.0%), silicone stent was removed because of tube-related complications, and the most common complication was canaliculitis (n = 8, 15.4%). CONCLUSIONS: Secondary intubation and maintenance of the stent is an effective and simple procedure for functional epiphora. The main obstacle to long-term maintenance is tube-associated canaliculitis. SN - 1476-5454 UR - https://www.unboundmedicine.com/medline/citation/31527764/Long-term_results_of_maintenance_of_lacrimal_silicone_stent_in_patients_with_functional_epiphora_after_external_dacryocystorhinostomy L2 - http://dx.doi.org/10.1038/s41433-019-0572-2 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.